Bill Text: FL S0242 | 2016 | Regular Session | Comm Sub
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Infectious Disease Elimination Pilot Program
Spectrum: Bipartisan Bill
Status: (Passed) 2016-03-23 - Chapter No. 2016-68 [S0242 Detail]
Download: Florida-2016-S0242-Comm_Sub.html
Bill Title: Infectious Disease Elimination Pilot Program
Spectrum: Bipartisan Bill
Status: (Passed) 2016-03-23 - Chapter No. 2016-68 [S0242 Detail]
Download: Florida-2016-S0242-Comm_Sub.html
Florida Senate - 2016 CS for SB 242 By the Committee on Health Policy; and Senators Braynon and Flores 588-01040-16 2016242c1 1 A bill to be entitled 2 An act relating to an infectious disease elimination 3 pilot program; creating the “Miami-Dade Infectious 4 Disease Elimination Act (IDEA)”; amending s. 381.0038, 5 F.S.; authorizing the University of Miami and its 6 affiliates to establish a sterile needle and syringe 7 exchange pilot program in Miami-Dade County; 8 establishing the pilot program criteria; providing 9 that the possession, distribution, or exchange of 10 needles and syringes under the pilot program is not a 11 violation of the Florida Comprehensive Drug Abuse 12 Prevention and Control Act or any other law; providing 13 conditions under which a pilot program staff member, 14 volunteer, or participant may be prosecuted; requiring 15 the pilot program to collect certain data; prohibiting 16 the collection of personal identifying information 17 from program participants; prohibiting state, county, 18 or municipal funds from being used to operate the 19 pilot program; requiring the pilot program to be 20 funded through private grants and donations; providing 21 for expiration of the pilot program; providing for 22 severability; providing an effective date. 23 24 Be It Enacted by the Legislature of the State of Florida: 25 26 Section 1. This act may be cited as the “Miami-Dade 27 Infectious Disease Elimination Act (IDEA).” 28 Section 2. Section 381.0038, Florida Statutes, is amended 29 to read: 30 381.0038 Education; sterile needle and syringe exchange 31 pilot program.—The Department of Health shall establish a 32 program to educate the public about the threat of acquired 33 immune deficiency syndrome. 34 (1) The acquired immune deficiency syndrome education 35 program shall: 36 (a) Be designed to reach all segments of Florida’s 37 population; 38 (b) Contain special components designed to reach non 39 English-speaking and other minority groups within the state; 40 (c) Impart knowledge to the public about methods of 41 transmission of acquired immune deficiency syndrome and methods 42 of prevention; 43 (d) Educate the public about transmission risks in social, 44 employment, and educational situations; 45 (e) Educate health care workers and health facility 46 employees about methods of transmission and prevention in their 47 unique workplace environments; 48 (f) Contain special components designed to reach persons 49 who may frequently engage in behaviors placing them at a high 50 risk for acquiring acquired immune deficiency syndrome; 51 (g) Provide information and consultation to state agencies 52 to educate all state employees;and53 (h) Provide information and consultation to state and local 54 agencies to educate law enforcement and correctional personnel 55 and inmates;.56 (i) Provide information and consultation to local 57 governments to educate local government employees;.58 (j) Make information available to private employers and 59 encourage them to distribute this information to their 60 employees;.61 (k) Contain special components which emphasize appropriate 62 behavior and attitude change; and.63 (l) Contain components that include information about 64 domestic violence and the risk factors associated with domestic 65 violence and AIDS. 66 (2) The education program designed by the Department of 67 Health shall useutilizeall forms of the media and shall place 68 emphasis on the design of educational materials that can be used 69 by businesses, schools, and health care providers in the regular 70 course of their business. 71 (3) The department may contract with other persons in the 72 design, development, and distribution of the components of the 73 education program. 74 (4) The University of Miami and its affiliates may 75 establish a single sterile needle and syringe exchange pilot 76 program in Miami-Dade County. The pilot program may operate at a 77 fixed location or through a mobile health unit. The pilot 78 program shall offer the free exchange of clean, unused needles 79 and hypodermic syringes for used needles and hypodermic syringes 80 as a means to prevent the transmission of HIV, AIDS, viral 81 hepatitis, or other blood-borne diseases among intravenous drug 82 users and their sexual partners and offspring. 83 (a) The pilot program must: 84 1. Provide for maximum security of exchange sites and 85 equipment, including an accounting of the number of needles and 86 syringes in use, the number of needles and syringes in storage, 87 safe disposal of returned needles, and any other measure that 88 may be required to control the use and dispersal of sterile 89 needles and syringes. 90 2. Operate a one-to-one exchange, whereby the participant 91 shall receive one sterile needle and syringe unit in exchange 92 for each used one. 93 3. Make available educational materials; HIV, AIDS, and 94 viral hepatitis counseling and testing; referral services to 95 provide education regarding the transmission of HIV, AIDS, viral 96 hepatitis, and other blood-borne diseases; and drug abuse 97 prevention and treatment counseling and referral services. 98 (b) The possession, distribution, or exchange of needles or 99 syringes as part of the pilot program established under this 100 subsection is not a violation of any part of chapter 893 or any 101 other law. 102 (c) A pilot program staff member, volunteer, or participant 103 is not immune from criminal prosecution for: 104 1. The possession of needles or syringes that are not a 105 part of the pilot program; or 106 2. The redistribution of needles or syringes in any form, 107 if acting outside the pilot program. 108 (d) The pilot program must collect data for annual and 109 final reporting purposes, which must include information on the 110 number of participants served, the number of needles and 111 syringes exchanged and distributed, the demographic profiles of 112 the participants served, the number of participants entering 113 drug counseling and treatment, the number of participants 114 receiving testing for HIV, AIDS, viral hepatitis, or other 115 blood-borne diseases, and other data deemed necessary for the 116 pilot program. However, personal identifying information may not 117 be collected from a participant for any purpose. 118 (e) State, county, or municipal funds may not be used to 119 operate the pilot program. The pilot program shall be funded 120 through grants and donations from private resources and funds. 121 (f) The pilot program shall expire July 1, 2020. 122 Section 3. If any provision of this act or its application 123 to any person or circumstance is held invalid, the invalidity 124 does not affect other provisions or applications of the act 125 which can be given effect without the invalid provision or 126 application, and to this end the provisions of this act are 127 severable. 128 Section 4. This act shall take effect July 1, 2016.